DK0782630T3 - Polycystisk nyresygdomsgen - Google Patents

Polycystisk nyresygdomsgen

Info

Publication number: DK0782630T3
Authority: DK; Denmark
Prior art keywords: pkd1; kidney disease; polycystic kidney; gene; disease gene
Prior art date: 1994-10-12

Application number

DK95938775T

Other languages

English (en)

Inventor

Katherine W Klinger

Gregory M Landes

Timothy C Burn

Timothy D Connors

William Dackowski

Gregory Germino

Feng Qian

Original Assignee

Genzyme Corp

Univ Johns Hopkins

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-12

Filing date

1995-10-11

Publication date

2006-05-29

1994-10-12 Priority claimed from US08/323,443 external-priority patent/US5654170A/en

1995-10-11 Application filed by Genzyme Corp, Univ Johns Hopkins filed Critical Genzyme Corp

2006-05-29 Application granted granted Critical

2006-05-29 Publication of DK0782630T3 publication Critical patent/DK0782630T3/da

Links

108090000623 proteins and genes Proteins 0.000 title abstract 2
208000030761 polycystic kidney disease Diseases 0.000 title 1
230000037416 cystogenesis Effects 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
108700009994 polycystic kidney disease 1 Proteins 0.000 abstract 2
101100029888 Homo sapiens PKD1 gene Proteins 0.000 abstract 1
101001074444 Homo sapiens Polycystin-1 Proteins 0.000 abstract 1
102100036143 Polycystin-1 Human genes 0.000 abstract 1
210000002919 epithelial cell Anatomy 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Urology & Nephrology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
External Artificial Organs (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK95938775T 1994-10-12 1995-10-11 Polycystisk nyresygdomsgen DK0782630T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/323,443 US5654170A (en)	1994-10-12	1994-10-12	Polycystic kidney disease gene
US38152095A	1995-01-31	1995-01-31

Publications (1)

Publication Number	Publication Date
DK0782630T3 true DK0782630T3 (da)	2006-05-29

Family

ID=26983965

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95938775T DK0782630T3 (da)	1994-10-12	1995-10-11	Polycystisk nyresygdomsgen

Country Status (10)

Country	Link
US (1)	US6867288B1 (da)
EP (1)	EP0782630B1 (da)
AT (1)	ATE316136T1 (da)
AU (1)	AU706167B2 (da)
CA (1)	CA2202283A1 (da)
DE (1)	DE69534753T2 (da)
DK (1)	DK0782630T3 (da)
ES (1)	ES2256851T3 (da)
PT (1)	PT782630E (da)
WO (1)	WO1996012033A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6824767B2 (en) *	1994-11-07	2004-11-30	Human Genome Sciences, Inc.	Tumor necrosis factor-gamma
US6599719B2 (en) *	1994-11-07	2003-07-29	Human Genome Sciences, Inc.	Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
EP0918855A1 (en) *	1996-05-24	1999-06-02	Genzyme Corporation	Polycystic kidney disease gene
DE19650758C1 (de) *	1996-12-06	1998-01-02	Deutsches Krebsforsch	PKD1-Fragmente mit Bindungsregionen für PKD1-spezifische Antikörper
WO1999011799A2 (en) *	1997-09-02	1999-03-11	Medical College Of Georgia Research Institute, Inc.	Human aminopeptidase p gene
AU2001271998A1 (en)	2000-07-13	2002-01-30	The Johns Hopkins University School Of Medicine	Detection and treatment of polycystic kidney disease
CA2993381C (en)	2006-07-24	2020-07-14	Athena Diagnostics, Inc.	Method of detecting the occurrence of adpkd based on presence of nucleotide sequence alteration in pkd1
US8424594B2 (en) *	2007-12-10	2013-04-23	Presto Engineering, Inc.	Apparatus for thermal control in the analysis of electronic devices
US20140037549A1 (en) *	2011-02-16	2014-02-06	Compugen Ltd.	Genetic markers for prognosis of rheumatoid arthritis treatment efficacy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0733110A1 (en) *	1993-12-24	1996-09-25	University of Wales College of Medicine	Tuberous sclerosis 2 gene and uses thereof
AU2892195A (en) *	1994-06-14	1996-01-05	Erasmus University Rotterdam	Polycystic kidney disease 1 gene and uses thereof
US6071717A (en) *	1995-01-31	2000-06-06	Genzyme Corporation	Polycystic kidney disease gene and protein

1995
- 1995-06-02 US US08/460,215 patent/US6867288B1/en not_active Expired - Lifetime
- 1995-10-11 AU AU40027/95A patent/AU706167B2/en not_active Ceased
- 1995-10-11 CA CA002202283A patent/CA2202283A1/en not_active Abandoned
- 1995-10-11 WO PCT/US1995/013357 patent/WO1996012033A1/en not_active Ceased
- 1995-10-11 AT AT95938775T patent/ATE316136T1/de active
- 1995-10-11 EP EP95938775A patent/EP0782630B1/en not_active Expired - Lifetime
- 1995-10-11 PT PT95938775T patent/PT782630E/pt unknown
- 1995-10-11 DK DK95938775T patent/DK0782630T3/da active
- 1995-10-11 ES ES95938775T patent/ES2256851T3/es not_active Expired - Lifetime
- 1995-10-11 DE DE69534753T patent/DE69534753T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US6867288B1 (en)	2005-03-15
PT782630E (pt)	2006-06-30
ES2256851T3 (es)	2006-07-16
AU706167B2 (en)	1999-06-10
CA2202283A1 (en)	1996-04-25
WO1996012033A1 (en)	1996-04-25
AU4002795A (en)	1996-05-06
EP0782630A4 (en)	1997-12-17
JP2001520502A (ja)	2001-10-30
DE69534753D1 (de)	2006-04-06
EP0782630A1 (en)	1997-07-09
ATE316136T1 (de)	2006-02-15
DE69534753T2 (de)	2006-11-02
EP0782630B1 (en)	2006-01-18
JP4495255B2 (ja)	2010-06-30

Publication	Publication Date	Title
WO1998026747A3 (en)	1998-09-17	Superantigen based methods and compositions for treatment of diseases
ZA200200789B (en)	2003-01-29	Multiple cytokine-antibody complexes.
AUPN568095A0 (en)	1995-10-26	Anti-Galalpha(1,3)Gal antibody binding peptides
ATE202706T1 (de)	2001-07-15	Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE69410254D1 (de)	1998-06-18	Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
AU1679795A (en)	1995-08-01	Anti-fungal methods and materials
DE69719754D1 (de)	2003-04-17	Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ATE281528T1 (de)	2004-11-15	Rekombinante ribonuklease proteine
EP0782630A4 (en)	1997-12-17	GENES OF RENAL POLYKYSTOSIS
ATE527358T1 (de)	2011-10-15	Ribosomen inaktivierendes protein vom typ-1
ATE251886T1 (de)	2003-11-15	Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
NO963487L (no)	1996-08-28	Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
FI961584A0 (fi)	1996-04-11	C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
DE69839943D1 (de)	2008-10-09	Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
DK0938329T3 (da)	2002-09-09	Immunogen TLP sammensætning
EP0770137A4 (en)	1999-10-27	IMPROVEMENTS IN PROTEIN PRODUCTION IN HOST CELLS
DE58907373D1 (de)	1994-05-11	Modifizierte Proteine.
NZ334762A (en)	2000-10-27	Human DNase I variants having binding affinity to actin
AU6942896A (en)	1997-03-27	Use of muteins of wild-type cytokines as immunogens
IT1276765B1 (it)	1997-11-03	Gene del cromosoma x umano e proteina codificata da detto gene.
MX9605330A (es)	1998-02-28	Metodos y composiciones para el tratamiento de glomerulonefritis y otras enfermedades inflamatorias.